Krystal Biotech, Inc.

Krystal Biotech, Inc.

KRYS
Krystal Biotech, Inc.US flagNASDAQ Global Market
301.82
USD
+8.61
- -
8.90BMarket Cap

Income Statement (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
51
291
389
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
51
291
389
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
3
20
23
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
3
20
23
Gross Profit
- -
- -
- -
- -
- -
- -
- -
48
270
366
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
1
5
12
22
33
68
120
145
167
205
+ Selling, General & Admin
- -
2
4
6
15
40
78
98
114
147
+ Research & Development
1
3
8
16
18
28
42
46
54
58
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
-5
-12
-22
-33
-68
-120
-97
103
161
- Non-Operating (Income) Loss
- -
3
-1
-3
-1
1
20
-110
8
-28
+ Interest Expense, Net
- -
3
1
-3
-1
1
-5
-23
-30
-28
+ Interest Expense
- -
3
1
- -
- -
1
- -
- -
- -
- -
- Interest Income
- -
- -
- -
3
1
- -
5
23
30
28
+ Other Non-Op (Income) Loss
- -
- -
-2
- -
- -
- -
25
-88
38
- -
Pretax Income
-1
-8
-11
-19
-32
-70
-140
13
95
189
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
2
6
-15
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-8
-11
-19
-32
-70
-140
11
89
205
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-8
-11
-19
-32
-70
-140
11
89
205
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-8
-11
-19
-32
-70
-140
11
89
205
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-8
-11
-19
-32
-70
-140
11
89
205
EBIT
-1
-5
-12
-22
-33
-68
-120
-97
103
161
EBITDA
-1
-5
-12
-21
-31
-66
-117
-91
110
168
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
-179.9
37.85
43.13
EBITA
-1
-5
-12
-22
-33
-68
-120
-97
103
161
Gross Margin (%)
- -
- -
- -
- -
- -
- -
- -
93.9
93.09
94.08
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
-191.56
35.54
41.45
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
21.56
30.69
52.64
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
2
2
3
6
7
7
Basic Weighted Avg Shares
4
5
11
16
19
22
25
27
29
29
Basic EPS, GAAP
-0.27
-1.48
-0.97
-1.2
-1.71
-3.13
-5.49
0.4
3.12
7.08
Basic EPS from Cont Ops
-0.27
-1.48
-0.97
-1.2
-1.71
-3.13
-5.49
0.4
3.12
7.08
Diluted Weighted Avg Shares
4
5
11
16
19
22
25
28
30
30
Diluted EPS, GAAP
-0.27
-1.48
-0.97
-1.2
-1.71
-3.13
-5.49
0.39
3
6.84
Diluted EPS from Cont Ops
-0.27
-1.48
-0.97
-1.2
-1.71
-3.13
-5.49
0.39
3
6.84

Balance Sheet (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
2
50
113
196
275
442
384
588
742
1,025
+ Cash, Cash Equivalents & STI
2
50
112
194
271
438
379
532
598
828
+ Cash & Cash Equivalents
2
50
104
188
268
341
162
358
345
496
+ ST Investments
- -
- -
8
6
3
97
217
174
253
331
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
- -
42
105
127
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
42
105
127
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
7
27
40
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
3
14
16
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
3
11
15
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
1
2
9
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
1
2
4
4
5
7
13
29
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
3
13
36
184
175
230
314
309
+ Property, Plant & Equip, Net
- -
- -
3
11
34
120
170
168
161
158
+ Property, Plant & Equip
- -
- -
3
12
37
124
177
181
183
189
- Accumulated Depreciation
- -
- -
- -
1
2
4
7
13
22
31
+ LT Investments & Receivables
- -
- -
- -
- -
- -
64
5
62
152
128
+ LT Investments
- -
- -
- -
- -
- -
64
5
62
152
128
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
1
2
- -
- -
- -
- -
23
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
1
2
- -
- -
- -
- -
23
Total Assets
2
50
116
209
311
626
558
818
1,056
1,334
+ Payables & Accruals
- -
1
3
3
7
25
27
29
98
98
+ Accounts Payable
- -
- -
1
1
2
8
4
4
5
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
2
4
11
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
2
2
5
16
23
23
89
83
+ ST Debt
- -
- -
- -
- -
8
1
2
1
1
2
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
8
1
2
1
1
2
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
2
2
4
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
2
2
4
Total Current Liabilities
- -
1
3
3
15
26
29
33
102
103
+ LT Debt
2
- -
- -
3
3
7
7
7
6
8
+ LT Borrowings
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
3
3
7
7
7
6
8
+ Other LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
1
4
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
1
4
Total Noncurrent Liabilities
2
- -
- -
3
3
7
7
7
7
11
Total Liabilities
2
1
3
6
19
33
36
40
109
114
+ Preferred Equity and Hybrid Capital
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
59
133
242
363
735
804
1,048
1,127
1,194
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
59
133
242
363
735
804
1,048
1,127
1,194
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-1
-9
-20
-39
-71
-141
-281
-270
-181
24
+ Other Equity
- -
- -
- -
- -
- -
- -
-1
1
- -
1
Equity Before Minority Interest
- -
49
113
203
292
594
522
779
946
1,220
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
49
113
203
292
594
522
779
946
1,220
Total Liabilities & Equity
2
50
116
209
311
626
558
818
1,056
1,334
Shares Outstanding
10
10
14
17
20
25
26
28
29
29
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
3
12
8
9
8
7
9
Net Debt
- -
-50
-104
-188
-268
-341
-162
-358
-345
-496
Net Debt to Equity
-27.68
-100.24
-91.56
-92.41
-91.85
-57.49
-31
-46.02
-36.44
-40.7
Tangible Common Equity Ratio
-51.19
98.72
97.51
97.08
93.96
94.78
93.51
95.15
89.63
91.44
Current Ratio
50.44
77.99
43.39
58.88
17.8
17.18
13.3
17.76
7.28
9.95
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
416.44
354.87
598.71

Cash Flow Statement (USD)

APIChat
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-1
-8
-11
-19
-32
-70
-140
11
89
205
+ Depreciation & Amortization
- -
- -
- -
1
2
2
3
6
7
7
+ Non-Cash Items
- -
4
1
1
3
17
33
-67
42
26
+ Stock-Based Compensation
- -
- -
1
1
3
15
33
40
49
55
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
-23
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
3
- -
- -
- -
2
- -
-107
-7
-6
+ Chg in Non-Cash Work Cap
- -
- -
1
-2
1
3
3
-39
-14
-36
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
-42
-63
-22
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
-4
-12
-6
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
-1
-2
-1
-1
-2
-9
-15
+ Inc (Dec) in Accts Payable
- -
1
1
- -
3
3
4
10
68
5
+ Inc (Dec) in Other
- -
- -
- -
-1
- -
- -
-1
-1
1
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
-4
-9
-19
-26
-48
-101
-89
123
201
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-2
-6
-15
-68
-53
-12
-4
-12
+ Acq of Fixed Prod Assets
- -
- -
-2
-6
-15
-68
-53
-12
-4
-12
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
42
74
108
118
356
29
160
- -
- -
+ Increase in Capital Stock
- -
42
74
108
118
356
29
160
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-8
1
4
-158
-61
-6
-159
-47
+ Dec in LT Investment
- -
- -
- -
11
7
32
258
503
299
376
+ Inc in LT Investment
- -
- -
-8
-9
-3
-190
-319
-509
-458
-423
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
100
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-10
-5
-11
-227
-114
83
-163
-58
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
2
2
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
2
2
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
1
7
- -
- -
- -
-8
6
43
27
9
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
3
52
74
108
118
348
35
203
27
9
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
2
48
54
84
81
73
-179
197
-13
151
EBITDA
-1
-5
-12
-21
-31
-66
-117
-91
110
168
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
-179.9
37.85
43.13
Free Cash Flow
-1
-4
-12
-25
-41
-116
-154
-101
119
189
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
-101
119
- -
Free Cash Flow to Equity
- -
-3
-12
-25
-41
-116
-154
-101
119
189
Free Cash Flow per Basic Share
-0.31
-0.76
-1.04
-1.58
-2.18
-5.24
-6.02
-3.7
4.17
6.53
Price/Free Cash Flow
- -
-15.32
-32.28
-71.65
-100.29
76.12
-42.43
-44.71
36.5
34.7
Cash Flow to Net Income
1.14
0.49
0.87
0.98
0.81
0.69
0.72
-8.12
1.38
0.98
Capital Expenditures
- -
- -
-2
-6
-15
-68
-53
-12
-4
-12